Callan Capital »

Poseida Therapeutics I shares owned by Callan Capital

Quarter-by-quarter ownership of Poseida Therapeutics I (PSTX) shares owned by Callan Capital from 13F filings

Historical chart of Callan Capital investment in Poseida Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Poseida Therapeutics I held by Callan Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Poseida Therapeutics I by Callan Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $257k 77k 3.36
2023-09-30 $182k 77k 2.38
2023-06-30 $128k 73k 1.76
2023-03-31 $210k 68k 3.08
2022-12-31 $330k 62k 5.30

More positions owned by Callan Capital

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Schwab Strategic Tr Schwab Fdt Us Bm (FNDB)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Apple (AAPL)
Ishares Tr Intl Eqty Factor (INTF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Select Sector Spdr Tr Technology (XLK)
Spdr Ser Tr Portfoli S&p1500 (SPTM)

View all positions for Callan Capital

Top funds holding Poseida Therapeutics I

Pentwater Capital Management
Vanguard Group
Aisling Capital Management
William Blair $ Company
Millennium Management
Charles Schwab Investment Management
Dimensional Fund Advisors
Goldman Sachs Group
Jacobs Levy Equity Management
Connor, Clark & Lunn Investment Management
Point72 Asset Management
MCF Advisors
Bank of America Corporation
Bank of New York Mellon
Barclays

View all funds holding Poseida Therapeutics I